Lecap Asset Management Ltd. lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) by 32.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,512 shares of the company’s stock after selling 4,043 shares during the period. Lecap Asset Management Ltd.’s holdings in Azenta were worth $448,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Federated Hermes Inc. lifted its stake in Azenta by 29.2% in the fourth quarter. Federated Hermes Inc. now owns 365,506 shares of the company’s stock worth $23,809,000 after acquiring an additional 82,502 shares during the period. Otter Creek Advisors LLC bought a new stake in shares of Azenta during the 4th quarter valued at about $1,511,000. Redwood Investment Management LLC purchased a new position in shares of Azenta during the first quarter valued at about $1,497,000. Susquehanna Fundamental Investments LLC bought a new position in Azenta in the first quarter worth about $615,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in Azenta in the fourth quarter worth about $1,973,000. Institutional investors own 99.08% of the company’s stock.
Azenta Stock Performance
Shares of Azenta stock traded down $0.80 during midday trading on Thursday, hitting $48.60. The company had a trading volume of 63,718 shares, compared to its average volume of 472,367. Azenta, Inc. has a 52-week low of $44.00 and a 52-week high of $69.16. The stock has a market capitalization of $2.62 billion, a P/E ratio of -18.23 and a beta of 1.51. The company has a 50 day moving average of $54.79 and a 200 day moving average of $56.54.
Analyst Upgrades and Downgrades
AZTA has been the subject of several research reports. Needham & Company LLC reissued a “buy” rating and issued a $69.00 target price on shares of Azenta in a research report on Wednesday, August 7th. Evercore ISI raised their price objective on Azenta from $52.00 to $53.00 and gave the company an “in-line” rating in a research report on Tuesday, July 2nd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Azenta presently has a consensus rating of “Hold” and an average price target of $67.00.
Read Our Latest Stock Analysis on AZTA
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
- Five stocks we like better than Azenta
- How to Use the MarketBeat Dividend Calculator
- 4 No-Brainer Stocks to Hold This Fall for Steady Gains
- What Is WallStreetBets and What Stocks Are They Targeting?
- McDonald’s Stock Nearing New High After Analyst Price Boost
- What is an Earnings Surprise?
- Palo Alto Networks Stock Can Set a New All-Time High Soon
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.